Key result
Pinostrobin reduces aortic valve calcification and cuts osteogenic RUNX2 expression by ~50% in vitro.
Why the study?
No effective drug therapy exists for aortic valve calcification, which involves Notch-mediated osteogenic differentiation of aortic valve interstitial cells. Although the bioflavonoid pinostrobin decreases Notch signaling in lung carcinoma cells, its effect on human aortic valve interstitial cells was not investigated.
Does pinostrobin suppress Notch signaling and osteogenic differentiation in human aortic valve interstitial cells in vitro?
Does pinostrobin suppress Notch signaling and osteogenic differentiation in human aortic valve interstitial cells in vitro?
Pinostrobin inhibits Notch signaling and suppresses osteogenic differentiation of human aortic valve interstitial cells in vitro, making it a promising candidate for further research in calcific aortic valve disease.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for pharmacologic prevention of calcific aortic valve disease; leaves open whether pinostrobin can safely attenuate valve calcification in vivo.
Background. Pinostrobin (5-hydroxy-7-methoxyflavanone) is a food bioflavonoid with various pharmacological effects; in the only study available to date, performed on human lung carcinoma cells, a dose-dependent decrease in the expression of Notch signaling components was described under the action of pinostrobin. The Notch signaling pathway plays an important role in the differentiation of interstitial cells of the aortic valve towards the osteogenic line, and its disruption contributes to the development of calcification of the aortic valve, various stages of which are found in at least 26 % of people over 65 years of age. No effective drug therapy for this disease is available, and treatment is only possible surgically, which carries a high risk for patients and places a significant burden on healthcare systems. Objective. The purpose of this study was to investigate the effect of pinostrobin on Notch signaling and on osteogenic differentiation of human aortic valve interstitial cells in vitro. Materials and Methods. Experiments were performed on human aortic valve interstitial cells (VIC) obtained from patients with calcific aortic valve disease and on human umbilical vein endothelial cells (HUVEC). The effect of pinostrobin on the accumulation of calcium deposits during osteogenic differentiation was assessed. The effect of pinostrobin on the expression of Notch target genes was evaluated using quantitative real-time PCR. Notch signaling was modulated with lentiviral constructs carrying the NOTCH1 intracellular domain (NICD) or a short hairpin RNA against CSL/RBPJ (shCSL). α-smooth muscle actin and vimentin were assessed by immunofluorescence staining. Pinostrobin was isolated from the buds of Populus nigra. Results. 10 μM pinostrobin inhibited Notch signaling and suppressed osteogenic differentiation of interstitial aortic valve cells in vitro; cell number decreased by approximately 26 % with no morphological signs of cell death. Under the influence of pinostrobin, RUNX2 expression was reduced by almost half (p < 0.0001), and the intensity of alizarin red staining was reduced 1.5-fold (p = 0.0048) in an osteogenic environment compared to cells not exposed to pinostrobin. Conclusion. Our results suggest that pinostrobin may have the potential to inhibit osteogenic differentiation of aortic valve interstitial cells in vitro and may be a promising candidate for further research.
No takes yet. Share an insight, caveat, or question.
Владимировна et al. (2026) studied Calcific aortic valve disease. Pinostrobin vs. Cells not exposed to pinostrobin in an osteogenic environment was evaluated on Notch signaling (RUNX2 expression) and osteogenic differentiation (alizarin red staining intensity) (1.5-fold reduction in alizarin red staining; ~50% reduction in RUNX2 expression, p=<0.0001 for RUNX2; 0.0048 for alizarin red staining). Pinostrobin (10 μM) suppressed osteogenic differentiation of human aortic valve interstitial cells in vitro, reducing RUNX2 expression by ~50% and alizarin red staining 1.5-fold.
Synapse has enriched 10 related papers. Consider them for comparative context: